138891-01-7 Usage
Uses
Used in Pharmaceutical Industry:
3-Acetyl-2-(methylaminosulfonyl)thiophene is used as a chemical intermediate for the synthesis of pharmaceutical drugs. Its unique structure allows it to be a potential candidate for the development of new drugs with specific therapeutic properties.
Used in Chemical Industry:
In the chemical industry, 3-acetyl-2-(methylaminosulfonyl)thiophene is used as a building block in the synthesis of various organic compounds. Its versatile structure makes it suitable for the creation of new chemical entities with potential applications in different fields.
Used in Research and Development:
3-Acetyl-2-(methylaminosulfonyl)thiophene is utilized in research and development for its unique structural features. It can be explored for its potential in creating new materials, catalysts, or other chemical entities that can be applied in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 138891-01-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,8,8,9 and 1 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 138891-01:
(8*1)+(7*3)+(6*8)+(5*8)+(4*9)+(3*1)+(2*0)+(1*1)=157
157 % 10 = 7
So 138891-01-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H9NO3S2/c1-5(9)6-3-4-12-7(6)13(10,11)8-2/h3-4,8H,1-2H3
138891-01-7Relevant academic research and scientific papers
Sulfonamides useful as carbonic anhydrase inhibitors
-
, (2008/06/13)
Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.
Thiophene sulfonamides useful as carbonic anhydrase inhibitors
-
, (2008/06/13)
Thiophene sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.
